Vertex Pharmaceuticals Incorporated
Q1 2020 Earnings Call Transcript

Published: 29 Apr 2020

[Michael Partridge:]

Good evening. Welcome to the Vertex First Quarter 2020 Financial Results Conference Call. This is Michael Partridge, Senior Vice President of Investor Relations for Vertex. Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex’s CEO and President; Stuart Arbuckle, Chief Commercial Officer; and Charlie Wagner, Chief Financial Officer. We recommend that you access the webcast slides on our website as you listen to this call. This conference call is being recorded, and a replay will be available on our website. We will make forward-looking statements on this call that are subject to the risks and uncertainties discussed in detail in today’s press release and our filings with the Securities and Exchange Commission. These statements, including without limitation those regarding Vertex’s marketed CF medicines, our pipeline and Vertex’s future financial performance, are based on management’s current assumptions. Actual outcomes and events could differ materially. I will now turn the call over to Dr. Reshma Kewalramani. Reshma Kewalramani